key: cord-0686325-tnqqbeoi
authors: Templin, Christian; Manka, Robert; Cammann, Victoria Lucia; Szawan, Konrad Andreas; Gotschy, Alexander; Karolyi, Mihaly; Winnik, Stephan; Moch, Holger; Meyer, Philippe; Moreo, Antonella; Bossone, Eduardo; D'Ascenzo, Fabrizio; Secco, Gioel Gabrio; Mancone, Massimo; Infusino, Fabio; Gaido, Luca; Giammaria, Massimo; Wittstein, Ilan S.; Varga, Zsuzsanna; Ghadri, Jelena R.
title: Takotsubo Syndrome in Coronavirus Disease 2019
date: 2020-10-09
journal: Am J Cardiol
DOI: 10.1016/j.amjcard.2020.10.005
sha: 31c5530aa92c9e72b2a7fc6cbb8753a9169db674
doc_id: 686325
cord_uid: tnqqbeoi

nan

included and compared to 57 patients with COVID-19 alone and 3,215 patients with TTS to   elucidate features of COVID-19 patients who develop TTS and to infer the underlying   pathology. Furthermore, we have stratified COVID-19 patients with myocardial injury into 2 groups: those with wall motion abnormalities and those without.

While COVID-19 disproportionately affected men (68.0%), most patients with COVID-19+TTS were female (88.1%). Most COVID-19+TTS patients had either physical (72.7%) or emotional (18.2%) triggers, most likely from infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19+TTS also tended to be older (mean age 72.4 years) compared to patients with COVID-19 alone (mean age 58.5 years) and TTS (mean age 67.8 years). Chest pain was more common among patients with TTS, irrespective of COVID-19, while dyspnea was most prevalent among COVID-19 patients who develop TTS. Importantly, patients with COVID-19 who developed TTS had significantly worse outcomes in terms of rates of respiratory therapy or in-hospital death (70.0%) than traditional cases of TTS (18.6%).

Troponin and brain natriuretic peptide (BNP) levels were typically elevated at the time of admission in COVID-19 patients with myocardial injury, suggesting that the systemic inflammatory response may be precipitating troponin release in these patients. In contrast, in patients with COVID-19 and TTS, troponin and BNP levels were generally low upon admission but increased during hospitalization. Left ventricular ejection fraction was most significantly reduced in patients COVID-19+TTS among all the groups we analyzed, which correlated with the highest peak BNP values.

Some of these cases of COVID-19 associated myocardial injury had global wall motion impairment, which we postulate may actually be a form of TTS. Although TTS typically presents with regional wall motion abnormalities (e.g., apical ballooning), a 'globally' reduced form has also been observed. 1 It is conceivable that the cytokine storm and catecholamine surge in patients with COVID-19 may cause a 'global' form of TTS in which the basal myocardium is not able to compensate, leading to global hypokinesia ( Figure 1 ).

Patients with TTS also generally show localized edema in the region of the wall motion abnormality on CMR. Meanwhile, a marked biventricular pattern of myocardial edema has been reported in a case of COVID-19-associated myocardial injury. 2 We also observed a COVID-19 patient with TTS who showed marked edema in the region of the wall motion abnormality on CMR in addition to global edema ( Figure 1) . Indeed, as both TTS and COVID-19 can trigger microcirculatory dysfunction, 3 it is possible they could act jointly resulting in significant cardiac complications. In particular, the cytokine storm that occurs in COVID-19 may work in concert with the exaggerated sympathetic stimulation of TTS to activate similar (albeit currently unknown) pathways, resulting in severe microcirculatory dysfunction, global/regional myocardial edema, and decompensated acute heart failure.

Of note, we observed contraction band necrosis with mononuclear infiltration in four of six patients who died due to COVID-19 and underwent autopsy (Figure 1 ). In comparison to coagulation necrosis in myocardial ischemia, contraction band necrosis can be seen as a result of the biopsy procedure or reflects catecholamine toxicity and sympathetic hyperactivity. 4 Indeed, the presence of contraction band necrosis and mononuclear infiltr ation has been reported previously in TTS, 5 potentially reflecting sympathetic overdrive. Contraction bands in combination with mononuclear infiltration, argue against artifactual changes and is indicative of the acute phase of severe left ventricular dysfunction. Therefore, an earlier biopsy may reveal the true incidence of contraction band necrosis in cases of COVID-19 myocardial injury with impaired wall motion abnormalities and normal coronary arteries.

In summary, the severe inflammatory response that occurs in COVID-19 may work in concert with the exaggerated sympathetic stimulation of TTS to activate similar pathways, resulting in severe microcirculatory dysfunction, global/regional myocardial edema, and decompensated acute heart failure. We hypothesize the coronary microcirculatory disturbances resulting from the combination of COVID-19+TTS could trigger a sudden calcium influx, culminating in contraction band necrosis. Therefore, patients with a dual diagnosis of TTS and COVID are at increased risk of adverse events. 

Stress-Related Cardiomyopathy Syndromes

Potential Effects of Coronaviruses on the Cardiovascular System: A Review

Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries

Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery